| Literature DB >> 11839743 |
Nandini Kishore1, Q Khai Huynh, Sumathy Mathialagan, Troii Hall, Sharon Rouw, David Creely, Gary Lange, James Caroll, Beverley Reitz, Ann Donnelly, Hymavathi Boddupalli, Rodney G Combs, Kuniko Kretzmer, Catherine S Tripp.
Abstract
NF-kappaB is sequestered in the cytoplasm by the inhibitory IkappaB proteins. Stimulation of cells by agonists leads to the rapid phosphorylation of IkappaBs leading to their degradation that results in NF-kappaB activation. IKK-1 and IKK-2 are two direct IkappaB kinases. Two recently identified novel IKKs are IKK-i and TBK-1. We have cloned, expressed, and purified to homogeneity recombinant human (rh)IKK-i and rhTBK-1 and compared their enzymatic properties with those of rhIKK-2. We show that rhIKK-i and rhTBK-1 are enzymatically similar to each other. We demonstrate by phosphopeptide mapping and site-specific mutagenesis that rhIKK-i and rhTBK-1 are phosphorylated on serine 172 in the mitogen-activated protein kinase kinase activation loop and that this phosphorylation is necessary for kinase activity. Also, rhIKK-i and rhTBK-1 have differential peptide substrate specificities compared with rhIKK-2, the mitogen-activated protein kinase kinase activation loop of IKK-2 being a more favorable substrate than the IkappaBalpha peptide. Finally, using analogs of ATP, we demonstrate unique differences in the ATP-binding sites of rhIKK-i, rhTBK-1, and rhIKK-2. Thus, although these IKKs are structurally similar, their enzymatic properties may provide insights into their unique functions.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11839743 DOI: 10.1074/jbc.M110474200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157